The Mag

Real World Data, Biopesticides, 3D Bioprinting

In this issue:

  • Real World Data: Beyond clinical trials
  • Biopesticides: Next-generation antibodies expand beyond healthcare and into the world of agriculture
  • Drug development: 3D bioprinted tissues are set to improve predictivity of preclinical disease models
  • Bioeconomy: Lodz Declaration lays down blueprint for EU bioeconomy strategy & action plan update
  • Interview with Jurgen Dressel, Novartis litigation expert on the impact of the EPO Early Certainty
  • News from our partner associations European Biotechnology Network, EAPB, EDMA, DIA, BIO Deutschland and the Swiss Biotech Association
  • ... and our Special BioFairs Compass.